Steroidal contraceptive use update, United States, 1989-1994

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 3, 1996, Pages 141-147

  Gerstman, B Burt ^a   Burke, Laurie ^a   Delaney, Jeanne ^a   McLellan, Barbara ^a  

^a SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

Contraceptive, implanted; Contraceptives, injectable; Contraceptives, oral; Drug utilization

Indexed keywords

DESOGESTREL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESTRANOL; NORETHISTERONE; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CONTRACEPTION; DRUG MARKETING; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

EID: 0030008863     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199605)5:3<141::AID-PDS221>3.0.CO;2-8     Document Type: Article

References (12)

1. Gerstman, B. B., Gross, T. P., Kennedy, D. L., Tomita, D. K. and Bennett, R. C. Trends in the content and use of oral contraceptives in the United States, 1964-1988. American Journal of Public Health 1991; 81: 90-98.
2. National Prescription Audit, 1964-1992, IMS America, Ltd., Plymouth Meeting, PA.
3. National Prescription Audit Plus, 1992-1994, IMS America, Ltd., Plymouth Meeting, PA.
4. National Disease and Therapeutic Index, 1988-1992, IMS America, Ltd., Plymouth Meeting, PA.
5. US Drugstore Audit and Provider Perspective - Non-federal Hospitals (Formerly U.S. Hospital Audit), Combined Purchases, 1991-1994, IMS America, Ltd., Plymouth Meeting, PA.
6. Forrest, J. D. and Singh, S. Public-sector savings resulting from expenditures for contraceptive services. Family Planning Perspectives 1990; 22: 6-15.
7. Forrest, J. D. The delivery of family planning services in the United States. Family Planning Perspectives 1988; 20: 88-95.
8. Kaeser, L. Reconsidering the age limits on pill use. Family Planning Perspectives 1989; 20: 88-95.
9. Grimes, D. A. The safety of oral contraceptives: epidemiologic insights from the first 30 years. American Journal of Obstetrics and Gynecology 1992; 166: 1950-1954.
10. Kost, K., Forrest, J. D. and Harlap, A. Comparing the health risks and benefits of contraceptive choices. Family Planning Perspectives 1991 23: 54-61.
11. Wysowski, D. K. and Green, L. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch spontaneous reporting system. Obstetrics and Gynecology 1995; 85: 538-542.
12. Kolata, G. Will the lawyers kill off Norplant? The New York Times 1995; May 28: 3.